Cargando…
2,6-Bis[(S)-4-benzyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine
The commercially available title compound, C(25)H(23)N(3)O(2), has been known since 1993 [Nesper et al. (1993 ▶). Helv. Chim. Acta, 76, 2239–2249], but has not been structurally characterized until now. In the free ligand, the N atoms of both oxazoline rings point in opposite directions. The phenyl...
Autores principales: | Möller, Konstanze, Junge, Kathrin, Spannenberg, Anke, Beller, Matthias |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089107/ https://www.ncbi.nlm.nih.gov/pubmed/21754484 http://dx.doi.org/10.1107/S1600536811014061 |
Ejemplares similares
-
2,6-Bis[(4R,5R)-4,5-diphenyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine
por: Lin, Ning, et al.
Publicado: (2011) -
2,4,5-Tris(pyridin-4-yl)-4,5-dihydro-1,3-oxazole
por: Campos-Gaxiola, José J., et al.
Publicado: (2012) -
[2-Benzyl-3-(naphthalen-1-yl)-2,3-dihydro-1,2-oxazole-4,5-diyl]bis(phenylmethanone)
por: Sandhya, R., et al.
Publicado: (2014) -
2-(4,5-Dihydro-1,3-oxazol-2-yl)quinoline
por: Machado, Pablo, et al.
Publicado: (2007) -
[2,6-Bis(4,5-dihydro-1H-imidazol-2-yl)pyridine]dichloridomanganese(II)
por: Ren, Chun-Xia, et al.
Publicado: (2009)